Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	neuron development	AHI1 KIF1A BRINP1 CUL7 ANKRD27 RYK PTPRD CXCR4 AP5Z1 SEMA3B FSCN2 DMD CAMSAP1 RPGRIP1 DDR1 SEMA4B RASGRF1 SYNE1 APBB1 LAMC2 ALS2 CYFIP2 FRY CELSR3 CELSR2 PLXNC1 SAMD11 FUT9 KIAA1755 BRSK1 IKBKB CDH1 TNXB CDH11 NEUROG3 KDM1A EPHA8 NCKAP1L	4.99e-07	1463	225	38	GO:0048666
GeneOntologyBiologicalProcess	neuron projection morphogenesis	KIF1A CUL7 ANKRD27 RYK PTPRD CXCR4 SEMA3B DMD DDR1 SEMA4B SYNE1 APBB1 LAMC2 ALS2 CYFIP2 CELSR3 CELSR2 PLXNC1 KIAA1755 BRSK1 CDH1 CDH11 NEUROG3 KDM1A EPHA8 NCKAP1L	7.47e-07	802	225	26	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	KIF1A CUL7 ANKRD27 RYK PTPRD CXCR4 SEMA3B DMD DDR1 SEMA4B SYNE1 APBB1 LAMC2 ALS2 CYFIP2 CELSR3 CELSR2 PLXNC1 KIAA1755 BRSK1 CDH1 CDH11 NEUROG3 KDM1A EPHA8 NCKAP1L	1.10e-06	819	225	26	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	KIF1A CUL7 ANKRD27 RYK PTPRD CXCR4 SEMA3B DMD DDR1 SEMA4B SYNE1 APBB1 LAMC2 ALS2 CYFIP2 CELSR3 CELSR2 PLXNC1 KIAA1755 BRSK1 CDH1 CDH11 NEUROG3 KDM1A EPHA8 NCKAP1L	1.29e-06	826	225	26	GO:0048858
GeneOntologyBiologicalProcess	neuron projection development	AHI1 KIF1A CUL7 ANKRD27 RYK PTPRD CXCR4 AP5Z1 SEMA3B DMD CAMSAP1 DDR1 SEMA4B RASGRF1 SYNE1 APBB1 LAMC2 ALS2 CYFIP2 FRY CELSR3 CELSR2 PLXNC1 FUT9 KIAA1755 BRSK1 IKBKB CDH1 TNXB CDH11 NEUROG3 KDM1A EPHA8 NCKAP1L	1.44e-06	1285	225	34	GO:0031175
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	KIF1A CUL7 ANKRD27 RYK PTPRD CXCR4 SEMA3B SEMA4B SYNE1 APBB1 LAMC2 ALS2 CYFIP2 CELSR3 CELSR2 PLXNC1 KIAA1755 BRSK1 CDH1 CDH11 NEUROG3 EPHA8	2.53e-05	748	225	22	GO:0048667
GeneOntologyBiologicalProcess	cell morphogenesis	KIF1A CUL7 ANKRD27 RYK PTPRD CXCR4 SEMA3B DMD CAMSAP1 COL6A1 DDR1 SEMA4B SYNE1 APBB1 LAMC2 ALS2 CYFIP2 FRY CELSR3 CELSR2 PLXNC1 KIAA1755 BRSK1 CDH1 CDH11 NEUROG3 KDM1A EPHA8 NCKAP1L	4.51e-05	1194	225	29	GO:0000902
Domain	BRINP	BRINP3 BRINP1 BRINP2	1.75e-06	3	226	3	IPR033237
Domain	EGF	BRINP3 MUC3B ADAM11 F12 LAMC2 CELSR1 CELSR3 CELSR2 BRINP2 MUC4 TNXB HYAL2	3.07e-05	235	226	12	SM00181
Domain	Cadherin_CS	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	5.40e-05	109	226	8	IPR020894
Domain	CADHERIN_1	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	6.99e-05	113	226	8	PS00232
Domain	Cadherin	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	6.99e-05	113	226	8	PF00028
Domain	-	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	7.44e-05	114	226	8	2.60.40.60
Domain	CADHERIN_2	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	7.44e-05	114	226	8	PS50268
Domain	CA	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	7.91e-05	115	226	8	SM00112
Domain	Cadherin-like	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	8.41e-05	116	226	8	IPR015919
Domain	Cadherin	DCHS2 PCDH19 PCDHAC1 CELSR1 CELSR3 CELSR2 CDH1 CDH11	9.48e-05	118	226	8	IPR002126
Domain	AnnexinVIII	ANXA8L1 ANXA8	1.46e-04	2	226	2	IPR009115
Domain	Dystrophin	DMD UTRN	1.46e-04	2	226	2	IPR016344
Domain	MAC_perforin	BRINP3 BRINP1 BRINP2	1.97e-04	10	226	3	IPR001862
Domain	EGF-like_dom	MUC3B IMPG1 ADAM11 F12 LAMC2 CELSR1 CELSR3 CELSR2 MUC4 TNXB HYAL2	2.36e-04	249	226	11	IPR000742
Domain	GAIN_dom_N	CELSR1 CELSR3 CELSR2	2.69e-04	11	226	3	IPR032471
Domain	MACPF	BRINP3 BRINP1 BRINP2	2.69e-04	11	226	3	PF01823
Domain	GAIN	CELSR1 CELSR3 CELSR2	2.69e-04	11	226	3	PF16489
Domain	EGF-like_CS	MUC3B ADAM11 F12 LAMC2 CELSR1 CELSR3 CELSR2 MUC4 TNXB HYAL2 EPHA8	3.52e-04	261	226	11	IPR013032
Domain	MACPF	BRINP3 BRINP1 BRINP2	3.55e-04	12	226	3	SM00457
Domain	MACPF	BRINP3 BRINP1 BRINP2	3.55e-04	12	226	3	IPR020864
Domain	EGF_2	MUC3B ADAM11 F12 LAMC2 CELSR1 CELSR3 CELSR2 MUC4 TNXB HYAL2 EPHA8	4.00e-04	265	226	11	PS01186
Domain	EGF_LAM_2	LAMC2 CELSR1 CELSR3 CELSR2	4.47e-04	30	226	4	PS50027
Domain	EGF_LAM_1	LAMC2 CELSR1 CELSR3 CELSR2	4.47e-04	30	226	4	PS01248
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A TBC1D9B EPPK1 SREBF1 PEX6 TOR4A FYCO1 ZZEF1 MYORG PCNX2 ZBED4 SH3TC1 PIK3C2B XPO6 CAMSAP1 RIC1 GAREM1 SEMA4B DOCK9 NICN1 RTTN WRAP53 TEP1 CELSR1 CELSR3 RPAP1 CELSR2 SND1 FURIN DIP2C TNK2 MBD5	6.15e-12	1105	237	32	35748872
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	GTPBP4 PEX6 FASTKD5 CUL7 ZZEF1 NKRF TUFM PIK3R1 GLS CLTC NUP160 PGBD5 PTCD3 APOO PITRM1 TTC28 SYNM SYNE1 APBB1 DYNC2I1 RNF213 CCT2 WRAP53 FAM83B RPAP1 GTF3C2 SND1 TMPO HADHB POLDIP2 FTSJ3	3.99e-08	1496	237	31	32877691
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	FBXO41 DMD UTRN NUP160 CCDC93 TRIM2 SYNE1 CCNA2 EIF3H KDM1A	9.66e-08	151	237	10	17043677
Pubmed	The flamingo-related mouse Celsr family (Celsr1-3) genes exhibit distinct patterns of expression during embryonic development.	CELSR1 CELSR3 CELSR2	3.12e-07	3	237	3	11677057
Pubmed	Interactions of intermediate filament protein synemin with dystrophin and utrophin.	DMD UTRN SYNM	3.12e-07	3	237	3	16777071
Pubmed	Analysis of the expression and function of BRINP family genes during neuronal differentiation in mouse embryonic stem cell-derived neural stem cells.	BRINP3 BRINP1 BRINP2	3.12e-07	3	237	3	20025061
Pubmed	Identification and characterization of novel developmentally regulated neural-specific proteins, BRINP family.	BRINP3 BRINP1 BRINP2	3.12e-07	3	237	3	15193423
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TBC1D9B CUL7 MYORG GLS NUP160 RIC1 SEC14L1 SEMA4B SYNM ANKRD26 RNF213 DIP2C APPL1 KDM2A MORC3 MBD5	3.35e-07	493	237	16	15368895
Pubmed	A protein interaction landscape of breast cancer.	EPPK1 CENPB TOR4A CUL7 NKRF PIK3R1 CLTC GOLIM4 PTCD3 TTC28 LAMC2 CCNA2 FAM83B SND1 HADHB CDH1 PLIN3 FTSJ3	4.33e-07	634	237	18	34591612
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SCRN1 XPO6 KLHL8 TTC28 SYNE1 DOCK9 ALS2 PPFIA3 DIP2C APPL1 KDM2A	4.75e-07	225	237	11	12168954
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	ZZEF1 HELZ DMD DNAH8 NUP160 SYNE1 RTTN RNF213 CCT2 CELSR3	7.03e-07	187	237	10	26460568
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	IMPG1 LRRC32 SH3BP1 FASTKD5 GFPT1 TUFM H2BC13 ALG5 GLS CLTC GOLIM4 PIGO PTCD3 COL6A1 SEMA4B APOO PITRM1 RNF213 CCT2 ZFPL1 CYFIP2 CELSR2 SND1 LOX FURIN HADHB POLDIP2 MITD1	7.93e-07	1451	237	28	30550785
Pubmed	Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos.	SETD1A DYNC2I1 CELSR1 CELSR3 CELSR2	8.24e-07	26	237	5	37228654
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DLGAP1 DCHS2 KIF1A IFT172 GFPT1 RYR3 GDAP1L1 PTPRD PIK3R1 GLS CLTC UTRN TTC28 SYNM SYNE1 APBB1 DYNC2I1 CCT2 WRAP53 ZBTB44 FRY CELSR3 APPL1 POLDIP2 MORC3 MITD1	8.47e-07	1285	237	26	35914814
Pubmed	The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.	CELSR1 CELSR3 CELSR2	1.24e-06	4	237	3	37224017
Pubmed	G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy.	DMD UTRN CSF3	1.24e-06	4	237	3	25865621
Pubmed	Developmental expression profiles of Celsr (Flamingo) genes in the mouse.	CELSR1 CELSR3 CELSR2	1.24e-06	4	237	3	11850187
Pubmed	Mesenchymal Vangl1 and Vangl2 facilitate airway elongation and widening independently of the planar cell polarity complex.	CELSR1 CELSR3 CELSR2 CDH1	1.99e-06	14	237	4	39225402
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GTPBP4 SETD1A FYCO1 GFPT1 NKRF CDC16 CLTC CAMSAP1 NUP160 GTF3C2 SND1 CDH1 KDM1A FTSJ3	2.32e-06	440	237	14	34244565
Pubmed	Planar cell polarity controls pancreatic beta cell differentiation and glucose homeostasis.	CELSR1 CELSR3 CELSR2 CDH1 NEUROG3	2.44e-06	32	237	5	23177622
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GTPBP4 EPPK1 KIF1A CUL7 GFPT1 NKRF TUFM H2BC13 CLTC HELZ UTRN NUP160 PTCD3 CCT2 SND1 KDM1A FTSJ3	2.93e-06	653	237	17	22586326
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	DLGAP1 CUL7 PIK3C2B PTPRN2 PIK3R1 ABCG5 PPFIA3 CELSR3 CELSR2 TMPO ELK3 CDH11	3.12e-06	329	237	12	17474147
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	GTPBP4 EPPK1 SREBF1 ITIH4 CDC16 ALG5 DMD VSIG10L2 NUP160 PPP1R21 APOO SYNE1 APOB PPFIA3 ARPC2 CSF3 HADHB KDM1A	4.95e-06	754	237	18	35906200
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	ADAM11 ADAMTS20 COL6A1 APOO APOB TNXB	5.06e-06	64	237	6	22261194
Pubmed	Defining the membrane proteome of NK cells.	GTPBP4 FYCO1 ANKRD27 TUFM PIK3R1 ALG5 CLTC GOLIM4 HELZ CHST12 PIGO PPP1R21 DOCK9 RNF213 CYFIP2 PLXNC1 IGHMBP2 FURIN TMPO TNK2 EIF3H PLIN3 NCKAP1L	5.87e-06	1168	237	23	19946888
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TUFM DMXL1 CLTC CAMSAP1 NUP160 PTCD3 TTC28 SYNM APBB1 ANKRD26 RNF213 CCT2 APOB FAM83B AP4E1 FURIN TMPO ANO3	7.45e-06	777	237	18	35844135
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	FASTKD5 TUFM HAUS8 CDC16 AP5Z1 ALG5 GLS CLTC GOLIM4 NUP160 PTCD3 GTF3C2 TMPO HADHB KDM1A	8.11e-06	560	237	15	35241646
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	GTPBP4 CENPB PEX6 FASTKD5 CUL7 ZZEF1 NKRF TUFM ITIH4 SH3TC1 PIK3R1 CDC16 PCDH19 HELZ PTCD3 TTC28 RNF213 PPFIA3 TEP1 POLDIP2 KDM1A FTSJ3	9.30e-06	1116	237	22	31753913
Pubmed	The genetic origin of mouse annexin VIII.	ANXA8L1 RBP3 ANXA8	1.07e-05	7	237	3	9434938
Pubmed	Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues.	CELSR1 CELSR3 CELSR2	1.07e-05	7	237	3	17937400
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GTPBP4 DLGAP1 SH3BP1 FYCO1 ITIH4 PTPRD PTPRN2 CLTC FBXO41 CAMSAP1 SYNE1 PPFIA3 CYFIP2 ARPC2 FRY CELSR2 APPL1 BRSK1 CDH11 KDM1A	1.14e-05	963	237	20	28671696
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	EPPK1 FYCO1 ZZEF1 GFPT1 TUFM H2BC13 CLTC NQO1 UTRN SYNE1 CCT2 CYFIP2 DNAH1 ARPC2 SND1 MASTL HADHB BRSK1	1.24e-05	807	237	18	30575818
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DLGAP1 ANXA8L1 PLPPR3 SCRN1 CDC16 GLS CLTC FBXO41 HELZ CAMSAP1 PTCD3 RELCH DOCK9 APBB1 ANXA8 PPFIA3 ATE1 MICU3 CELSR2 IGHMBP2 APPL1 HADHB	1.27e-05	1139	237	22	36417873
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	HELZ CAMSAP1 UTRN TTC28 SYNM SH3GL3 APBB1 ANKRD26 FAM83B AP4E1	1.46e-05	263	237	10	34702444
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GTPBP4 KIF1A FASTKD5 GFPT1 TUFM CXCR4 CDC16 GLS CLTC NUP160 PTCD3 PITRM1 SYNE1 CCT2 APOB CYFIP2 ARPC2 GTF3C2 SND1 TMPO HADHB POLDIP2 EIF3H KDM1A FTSJ3	1.64e-05	1425	237	25	30948266
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	CUL7 TUFM COL6A1 SYNE1 RNF213 TEP1 CYFIP2 SND1 IKBKB	1.78e-05	214	237	9	22199357
Pubmed	The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.	GTPBP4 CUL7 NKRF CDC16 NUP160 PTCD3 SND1 HADHB FTSJ3	2.21e-05	220	237	9	34091597
Pubmed	Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data.	ABCG5 APOB CELSR2	2.55e-05	9	237	3	20370913
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD1A NKRF TUFM CDC16 CLTC TTC28 APBB1 CCT2 GTF3C2 SND1 TMPO KDM2A PLIN3 KDM1A	2.80e-05	549	237	14	38280479
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	EFCAB5 GTPBP4 NKRF TUFM CLTC DMD CAMSAP1 SYNE1 TMPO	3.58e-05	234	237	9	36243803
Pubmed	Epiplakin1 is expressed in the cholangiocyte lineage cells in normal liver and adult progenitor cells in injured liver.	EPPK1 AFP CDH1	3.62e-05	10	237	3	21216305
Pubmed	Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease.	ANXA8L1 CDK14 PTPRD ANXA8	3.79e-05	28	237	4	33953184
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	AHI1 CENPB IFT172 NKRF TULP3 HAUS8 CXCR4 XPO6 PIK3R1 CDC16 HELZ NUP160 CEP97 CCDC93 RPGRIP1 RELCH PITRM1 DYNC2I1 GTF3C2 SND1 APPL1 MORC3 KDM1A	4.07e-05	1321	237	23	27173435
Pubmed	Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.	DMD UTRN	4.62e-05	2	237	2	10525423
Pubmed	IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.	IKZF1 BCL2L1	4.62e-05	2	237	2	32396934
Pubmed	In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.	DMD UTRN	4.62e-05	2	237	2	28790199
Pubmed	Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.	DMD UTRN	4.62e-05	2	237	2	26974331
Pubmed	Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.	DMD UTRN	4.62e-05	2	237	2	7987307
Pubmed	Comparative analysis of the human dystrophin and utrophin gene structures.	DMD UTRN	4.62e-05	2	237	2	11861579
Pubmed	Distinct mechanical properties in homologous spectrin-like repeats of utrophin.	DMD UTRN	4.62e-05	2	237	2	30914715
Pubmed	Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.	DMD UTRN	4.62e-05	2	237	2	17889902
Pubmed	Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.	DMD UTRN	4.62e-05	2	237	2	37626761
Pubmed	Familial Hemophagocytic Lymphohistiocytosis With Heterozygous STX11 and Homozygous UNC13D Mutations Diagnosed in the Neonatal Period.	UNC13D STX11	4.62e-05	2	237	2	35293882
Pubmed	Chromosomal localization of Celsr2 and Celsr3 in the mouse; Celsr3 is a candidate for the tippy (tip) lethal mutant on chromosome 9.	CELSR3 CELSR2	4.62e-05	2	237	2	10790539
Pubmed	The N- and C-Terminal Domains Differentially Contribute to the Structure and Function of Dystrophin and Utrophin Tandem Calponin-Homology Domains.	DMD UTRN	4.62e-05	2	237	2	26516677
Pubmed	Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.	DMD UTRN	4.62e-05	2	237	2	22209498
Pubmed	Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.	DMD UTRN	4.62e-05	2	237	2	10694796
Pubmed	Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.	DMD UTRN	4.62e-05	2	237	2	24337461
Pubmed	Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.	DMD UTRN	4.62e-05	2	237	2	11297940
Pubmed	Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.	DMD UTRN	4.62e-05	2	237	2	22388933
Pubmed	Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.	DMD UTRN	4.62e-05	2	237	2	28785010
Pubmed	Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.	DMD UTRN	4.62e-05	2	237	2	16307000
Pubmed	Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.	DMD UTRN	4.62e-05	2	237	2	21949353
Pubmed	Annexins: from structure to function.	ANXA8L1 ANXA8	4.62e-05	2	237	2	11917092
Pubmed	Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.	DMD UTRN	4.62e-05	2	237	2	23097179
Pubmed	The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain.	DMD UTRN	4.62e-05	2	237	2	15501597
Pubmed	Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.	DMD UTRN	4.62e-05	2	237	2	18973234
Pubmed	Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.	DMD UTRN	4.62e-05	2	237	2	27881412
Pubmed	Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.	DMD UTRN	4.62e-05	2	237	2	29065908
Pubmed	Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.	DMD UTRN	4.62e-05	2	237	2	31039133
Pubmed	Mechanical and electrophysiological properties of the sarcolemma of muscle fibers in two murine models of muscle dystrophy: col6a1-/- and mdx.	DMD COL6A1	4.62e-05	2	237	2	20396399
Pubmed	Dystrophin and dystrophin-related protein in the brains of normal and mdx mice.	DMD UTRN	4.62e-05	2	237	2	8159184
Pubmed	Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.	DMD UTRN	4.62e-05	2	237	2	10679963
Pubmed	TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.	DMD UTRN	4.62e-05	2	237	2	21565990
Pubmed	Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles.	DMD UTRN	4.62e-05	2	237	2	8186702
Pubmed	Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.	DMD UTRN	4.62e-05	2	237	2	25940966
Pubmed	Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.	DMD UTRN	4.62e-05	2	237	2	22266080
Pubmed	Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.	DMD UTRN	4.62e-05	2	237	2	17300937
Pubmed	Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.	DMD UTRN	4.62e-05	2	237	2	21768542
Pubmed	Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity.	DMD UTRN	4.62e-05	2	237	2	33359740
Pubmed	Increased vulnerability to kainate-induced seizures in utrophin-knockout mice.	DMD UTRN	4.62e-05	2	237	2	12028357
Pubmed	Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study.	DMD UTRN	4.62e-05	2	237	2	20130206
Pubmed	Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.	DMD UTRN	4.62e-05	2	237	2	16525850
Pubmed	Distribution of dystrophin- and utrophin-associated protein complexes during activation of human neutrophils.	DMD UTRN	4.62e-05	2	237	2	20434517
Pubmed	Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice.	DMD UTRN	4.62e-05	2	237	2	24466085
Pubmed	Isolation and characterization of a genomic clone from the murine utrophin locus.	DMD UTRN	4.62e-05	2	237	2	8268660
Pubmed	Annexin A8 controls leukocyte recruitment to activated endothelial cells via cell surface delivery of CD63.	ANXA8L1 ANXA8	4.62e-05	2	237	2	24769558
Pubmed	Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.	DMD UTRN	4.62e-05	2	237	2	27037492
Pubmed	Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.	DMD UTRN	4.62e-05	2	237	2	16487708
Pubmed	Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart.	DMD UTRN	4.62e-05	2	237	2	21677768
Pubmed	Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.	DMD UTRN	4.62e-05	2	237	2	9713852
Pubmed	Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.	DMD UTRN	4.62e-05	2	237	2	25607927
Pubmed	Developmental studies of dystrophin-positive fibers in mdx, and DRP localization.	DMD UTRN	4.62e-05	2	237	2	8433092
Pubmed	Second-generation compound for the modulation of utrophin in the therapy of DMD.	DMD UTRN	4.62e-05	2	237	2	25935002
Pubmed	Dystrophin is a microtubule-associated protein.	DMD UTRN	4.62e-05	2	237	2	19651889
Pubmed	Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.	DMD UTRN	4.62e-05	2	237	2	29879154
Pubmed	Identification of Dp71 isoforms in the platelet membrane cytoskeleton. Potential role in thrombin-mediated platelet adhesion.	DMD UTRN	4.62e-05	2	237	2	12370193
Pubmed	BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.	DMD UTRN	4.62e-05	2	237	2	27750047
Pubmed	The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation.	SND1 CDH1	4.62e-05	2	237	2	37885030
Pubmed	Dystrophin and dystrophin-related protein in the central nervous system of normal controls and Duchenne muscular dystrophy.	DMD UTRN	4.62e-05	2	237	2	8171962
Interaction	TOP3B interactions	SETD1A TBC1D9B EPPK1 SREBF1 PEX6 TOR4A FYCO1 ZZEF1 TUFM MYORG PCNX2 ZBED4 SH3TC1 PIK3C2B XPO6 HELZ CAMSAP1 MOCS2 RIC1 GAREM1 SEMA4B DOCK9 NICN1 RTTN APOB WRAP53 TEP1 ARPC2 CELSR1 CELSR3 RPAP1 CELSR2 SND1 FURIN DIP2C TNK2 HADHB MBD5	1.54e-06	1470	229	38	int:TOP3B
Interaction	SIRT6 interactions	GTPBP4 SETD1A FYCO1 GFPT1 NKRF CDC16 CLTC NQO1 CAMSAP1 NUP160 DYNC2I1 CELSR1 CELSR3 CELSR2 GTF3C2 SND1 SAMD11 CDH1 MUTYH KDM1A FTSJ3	1.07e-05	628	229	21	int:SIRT6
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3 CELSR2	6.18e-07	3	155	3	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3 CELSR2	6.18e-07	3	155	3	1189
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	ZZEF1 DMD UTRN	4.59e-04	18	155	3	91
GeneFamily	Neuroblastoma breakpoint family	NBPF4 NBPF5P NBPF6	9.65e-04	23	155	3	662
Coexpression	GSE16266_CTRL_VS_LPS_STIM_MEF_UP	TOR4A SOCS6 SH3TC1 PIK3C2B CXCR4 CAMSAP1 SEMA4B LFNG FURIN ELK3 MORC3	1.82e-06	198	234	11	M7219
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	AHI1 SGSM1 ADAM11 RYR3 SYNE1 DOCK9 DYNC2I1 RNF213 TNK2 ANO3	2.62e-06	166	234	10	M39026
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	DLGAP1 CDK14 PTPRD GLS TTC28 ANKRD26 DYNC2I1 RNF213 DIP2C MBD5	4.41e-06	176	234	10	M39223
Coexpression	TRAVAGLINI_LUNG_CILIATED_CELL	EPPK1 IFT172 PEX6 BCL2L1 TUFM TULP3 DNAAF3 KIF9 PTPRN2 GFOD2 CDC16 NQO1 DMD CEP97 APOO SYNE1 APBB1 ANKRD26 DYNC2I1 LAMC2 WRAP53 DNAH1 CFAP74 ELK3 MUC4 PLIN3	5.79e-06	1093	234	26	M41649
ToppCell	Biopsy_Other_PF-Epithelial-KRT5-/KRT17+\|Biopsy_Other_PF / Sample group, Lineage and Cell type	EPPK1 KIF1A ANXA8L1 SEMA3B PGBD5 DDR1 KIF26B LAMC2 ANXA8 CELSR1 CDH1	1.06e-08	200	236	11	077e6b9340686de9d0f11b035a8954e1f6a1b790
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 TRANK1 PTPRD ADAMTS20 DMD OTOA KIF26B APOB DNAH1 ANO3	5.61e-08	184	236	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 TRANK1 PTPRD ADAMTS20 DMD OTOA KIF26B APOB DNAH1 ANO3	5.61e-08	184	236	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 TRANK1 PTPRD ADAMTS20 DMD OTOA KIF26B APOB DNAH1 ANO3	5.61e-08	184	236	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP1 AHI1 PCNX2 TRANK1 FBXO41 RASGRF1 PPFIA3 CYFIP2 CELSR2 BRINP2	8.79e-08	193	236	10	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP1 AHI1 PCNX2 TRANK1 FBXO41 RASGRF1 PPFIA3 CYFIP2 CELSR2 BRINP2	8.79e-08	193	236	10	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP1 AHI1 PCNX2 TRANK1 FBXO41 RASGRF1 PPFIA3 CYFIP2 CELSR2 BRINP2	8.79e-08	193	236	10	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	AHI1 RASL12 CDK14 PTPRD COL6A1 SYNE1 CSF3 KIAA1755 TNXB CDH11	1.17e-07	199	236	10	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A PCDH19 ADAMTS20 PGBD5 KIF26B LAMC2 KIAA1755 BRSK1 LRRD1	5.54e-07	181	236	9	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	Ciliated-cil-3\|World / Class top	IFT172 CFAP65 DNAAF3 KIF9 SYNE1 DYNC2I1 DNAH1 CFAP74 HDC	9.07e-07	192	236	9	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SH3BP1 PCNX2 TRANK1 PTPRN2 GLS FBXO41 PPFIA3 CYFIP2 MICU3	9.89e-07	194	236	9	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHI1 KIF1A GFPT1 PTPRN2 CLTC SEC14L1 TTC28 CYFIP2 MUC4	1.03e-06	195	236	9	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PIK3C2B UTRN SEC14L1 TTC28 DOCK9 ELK3 TNXB HYAL2	1.08e-06	196	236	9	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PIK3C2B UTRN SEC14L1 TTC28 DOCK9 ELK3 TNXB HYAL2	1.08e-06	196	236	9	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PIK3C2B UTRN SEC14L1 TTC28 DOCK9 ELK3 TNXB HYAL2	1.08e-06	196	236	9	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFT172 FASTKD5 PIK3C2B DNAH8 PPP1R21 TTC28 ALS2 MITD1	4.09e-06	173	236	8	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFT172 FASTKD5 PIK3C2B DNAH8 PPP1R21 TTC28 ALS2 MITD1	4.09e-06	173	236	8	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 UNC13D SEMA3B UTRN SH3GL3 LAMC2 CELSR1 CDH1	4.84e-06	177	236	8	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC13D SEMA3B UTRN DDR1 SH3GL3 LAMC2 CELSR1 CDH1	5.70e-06	181	236	8	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	UNC13D SEMA3B DDR1 APBB1 LAMC2 CHST8 STX11 CDH1	6.97e-06	186	236	8	521e6e007bbae73e7328153aa170cf04ca3c1093
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZZEF1 SH3TC1 CCDC93 TTC28 RNF213 LFNG GPR68 STX11	7.24e-06	187	236	8	4527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC13D SEMA3B UTRN DDR1 TSPEAR LAMC2 CELSR1 CDH1	7.24e-06	187	236	8	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	wk_15-18-Hematologic-Myeloid-Basophil\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	UNC13D IKZF1 F12 XPO6 LFNG STX11 LRRD1 HDC	7.53e-06	188	236	8	3638d85452de15a060146628fbbad9d2a36feb13
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ANXA8L1 DDR1 LAMC2 ANXA8 FAM83B CELSR1 CDH1 MUC4	7.53e-06	188	236	8	61422c7919ca0ea02d6be4302f11b169a3ce35e5
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ANXA8L1 DDR1 LAMC2 ANXA8 FAM83B CELSR1 CDH1 MUC4	7.53e-06	188	236	8	18698f0b22ccbc2b93759acc1c8dbdb30a6b5a16
ToppCell	Control-B_intermediate-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TBC1D9B SH3BP1 SCRN1 TRANK1 SIGLEC10 SEMA4B RNF213 PLXNC1	7.83e-06	189	236	8	11cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMC7 LRRC32 PIK3C2B UTRN TTC28 ELK3 TNXB HYAL2	8.78e-06	192	236	8	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRRC32 PIK3C2B UTRN SEC14L1 TTC28 DOCK9 ELK3 HYAL2	8.78e-06	192	236	8	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 RASL12 CDK14 PTPRD COL6A1 KIF26B KIAA1755 CDH11	8.78e-06	192	236	8	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 RASL12 CDK14 PTPRD COL6A1 TTC28 KIF26B CDH11	8.78e-06	192	236	8	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UTRN SYNM KIF26B DOCK9 TSPEAR LOX ELK3 HYAL2	9.12e-06	193	236	8	bd0027fa97de41ae22ff64a61c8e217496f122ca
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 RYR3 PIK3C2B UTRN SEC14L1 ELK3 TNXB HYAL2	1.02e-05	196	236	8	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	facs-Bladder-nan-3m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D9B CENPB RYK PIK3R1 CLTC CHST12 UTRN SND1	1.02e-05	196	236	8	c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCell	facs-Bladder-nan-3m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D9B CENPB RYK PIK3R1 CLTC CHST12 UTRN SND1	1.02e-05	196	236	8	44f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 RYR3 PIK3C2B UTRN SEC14L1 ELK3 TNXB HYAL2	1.02e-05	196	236	8	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB5 TRANK1 PTPRN2 CELSR2 ANKRD60 BRINP2 EPHA8	1.04e-05	141	236	7	4aa4b3476dc5abefbd348353cfe711cd5fe3d52f
ToppCell	facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB5 TRANK1 PTPRN2 CELSR2 ANKRD60 BRINP2 EPHA8	1.04e-05	141	236	7	e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RASL12 TULP3 PTPRD COL6A1 SYNE1 DYNC2I1 TNXB CDH11	1.06e-05	197	236	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	PLPPR3 F12 GDAP1L1 PTPRD PIK3R1 DOCK9 SH3GL3 CDH11	1.06e-05	197	236	8	10e72b425a2bcba35e63a5b074d3dedcd49a762e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 RYR3 PIK3C2B UTRN SEC14L1 DOCK9 ELK3 HYAL2	1.10e-05	198	236	8	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 RYR3 PIK3C2B UTRN SEC14L1 DOCK9 ELK3 HYAL2	1.10e-05	198	236	8	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TMC7 LRRC32 PIK3C2B UTRN TTC28 ELK3 TNXB HYAL2	1.10e-05	198	236	8	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DLGAP1 AHI1 BRINP1 CDK14 PTPRN2 GLS SYNE1 FRY	1.10e-05	198	236	8	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	LRRC32 PIK3C2B UTRN SEC14L1 DOCK9 ELK3 TNXB HYAL2	1.10e-05	198	236	8	8689090bce9ab6e8f122426a404037e572c6713b
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13D IKZF1 CDK14 SEC14L1 PLXNC1 BRSK1 STX11 NCKAP1L	1.14e-05	199	236	8	1bb02f41f3cc76a28581e38b0ca4c36b930b85b4
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CXCR4 PIK3R1 GLS HELZ UTRN SYNE1 RNF213 ELK3	1.14e-05	199	236	8	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TMC7 LRRC32 PIK3C2B CXCR4 NQO1 GOLIM4 SAMD11 HYAL2	1.18e-05	200	236	8	ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	PEX6 ADAM11 F12 NFKBIB PPP1R21 SH3GL3 WRAP53 MBD5	1.18e-05	200	236	8	6b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	TMC7 LRRC32 PIK3C2B NQO1 GOLIM4 DOCK9 FRY HYAL2	1.18e-05	200	236	8	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	SGSM1 PEX6 ADAM11 F12 XPO6 NFKBIB SH3GL3 ELK3	1.18e-05	200	236	8	be83f442179ba4217d12f0458059586ff3130991
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANXA8L1 DDR1 SEMA4B ARHGEF5 LAMC2 ANXA8 FAM83B MUC4	1.18e-05	200	236	8	2a9d715aba8bdef2341b0d44ff60825c074a4b03
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DCHS2 RYR3 CFAP65 KIF9 SEC14L1 CHST8 EPHA8	1.19e-05	144	236	7	08005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCell	facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM11 TULP3 DDR1 TPCN2 MAMDC4 GPR68 CFAP74	2.09e-05	157	236	7	5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446
ToppCell	facs-Marrow-KLS-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM11 TULP3 DDR1 TPCN2 MAMDC4 GPR68 CFAP74	2.09e-05	157	236	7	ad9c9b7dfeee3ae46e7e593c51a0407df12195b4
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAB19 TULP3 OTOA SAMD11 BRSK1 CDH1 HDC	2.99e-05	166	236	7	c22b0f3bf990d94b615a3aacee5de548da2db628
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAB19 TULP3 OTOA SAMD11 BRSK1 CDH1 HDC	2.99e-05	166	236	7	0975fc165bcc7e85f053d9d0244fffe407c23571
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC169 RAB19 RASGRF1 MAMDC4 CELSR1 STX11 CA5B	3.23e-05	168	236	7	6c758eb120faf06ff72d157b495e399191c79ec9
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	FASTKD5 CDK14 PIK3C2B KLHL8 TRIM2 CDH11 FTSJ3	3.23e-05	168	236	7	8459d0a1bf6d4b5c83001097331f8b78fceb9305
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	HAUS8 ZBED4 GOLIM4 RPGRIP1 TTC28 GTPBP8 CDH1	3.23e-05	168	236	7	ca94b29c1030484143a77f2df06dad74d2c6136e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GDAP1L1 PTPRD GOLIM4 NPHS1 FRY SAMD11 LOX	3.48e-05	170	236	7	60bbd738c12e64e483485586c30057304884f5a6
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	TMC7 LRRC32 PIK3C2B DOCK9 PPFIA3 FRY HYAL2	3.89e-05	173	236	7	ec88e871b49331fca59bc610a8ae58e2d5e76bc1
ToppCell	droplet-Heart-HEART-1m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 KIF26B SH3GL3 LFNG CYFIP2 CELSR1 LRRD1	3.89e-05	173	236	7	9dc7746a84f0e268a7c061e1bbcd5e31903034dc
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	TMC7 LRRC32 PIK3C2B DOCK9 PPFIA3 FRY HYAL2	3.89e-05	173	236	7	22200fe74e33e2beae0eed289ca8476bbc0b1b2d
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL2L1 F12 FBXO9 TRIM2 MAMDC4 HDC	4.14e-05	119	236	6	aa3860c8d25c85baa79a0b6637bce2e269adfcc2
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC13D CLTC SEMA3B DDR1 TPCN2 LAMC2 CDH1	4.18e-05	175	236	7	35fb7735dd3355476fe60404833cb60bd066bcf1
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 TMC7 RASL12 BDKRB1 CHST8 BRINP2 CFAP74	4.18e-05	175	236	7	cf15465855602ba135752c18755e3e058dbd42ec
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SETD1A UTRN RPGRIP1 DOCK9 TSPEAR LOX ELK3	4.18e-05	175	236	7	43be63976da5ad0764d24d90919a77ce46068f52
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 TMC7 RASL12 BDKRB1 CHST8 BRINP2 CFAP74	4.18e-05	175	236	7	d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC13D CLTC SEMA3B DDR1 TPCN2 LAMC2 CDH1	4.18e-05	175	236	7	442f261a3b2c4d2523f7d4089178f8c79cac2f0f
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TOR4A RYR3 CXCR4 SIGLEC10 ALS2 FRY HDC	4.18e-05	175	236	7	ba1befc4e5f0167452f9ceace39377d16136dfa9
ToppCell	COPD-Epithelial-Aberrant_Basaloid\|COPD / Disease state, Lineage and Cell class	ANXA8L1 PGBD5 DDR1 LAMC2 ANXA8 CELSR1 CDH1	4.34e-05	176	236	7	11d867bcb4f2471b4e13a5f7dc1c24286197f26d
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RASL12 BDKRB1 PTPRD GAREM1 KIAA1755 TNXB GPR176	4.50e-05	177	236	7	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLGAP1 ZSWIM1 DMD OTOA COL6A1 TTC28 KIAA1755	4.50e-05	177	236	7	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 UNC13D SEMA3B SH3GL3 LAMC2 CELSR1 CDH1	4.66e-05	178	236	7	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RYR3 PTPRD GOLIM4 NPHS1 TSPEAR FRY LOX	4.66e-05	178	236	7	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETD1A EPPK1 PTPRD RASGRF1 CHST8 DNAH1 MUTYH	4.83e-05	179	236	7	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 UNC13D SEMA3B DDR1 LAMC2 CELSR1 CDH1	4.83e-05	179	236	7	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL7 TULP3 SH3TC1 DNAH8 ASAH2 MICU3 TNXB	4.83e-05	179	236	7	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	COPD-Epithelial-Basal\|World / Disease state, Lineage and Cell class	ANXA8L1 LAMC2 ANXA8 FAM83B CELSR1 CDH1 MUC4	5.18e-05	181	236	7	6d8a886b4afe729f8a05b9c0f4ea9375de735da4
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	DCHS2 NPHS1 COL6A1 LOX BRINP2 TNXB CDH11	5.36e-05	182	236	7	354dcdb01360597f68c4fe157a682aee1c0b8bb1
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRD NQO1 GOLIM4 NPHS1 FRY SAMD11 LOX	5.36e-05	182	236	7	cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08
ToppCell	COPD-Epithelial-Basal\|COPD / Disease state, Lineage and Cell class	ANXA8L1 LAMC2 ANXA8 FAM83B CELSR1 CDH1 MUC4	5.55e-05	183	236	7	0f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SREBF1 GIMAP1 ITIH4 MAMDC4 CELSR1 PLXNC1 CDH11	5.55e-05	183	236	7	b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	UTRN SYNM TSPEAR CHST8 LOX ELK3 TNXB	5.55e-05	183	236	7	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PIK3C2B SYNM DOCK9 TSPEAR ELK3 TNXB HYAL2	5.55e-05	183	236	7	bc98df870de65aff6dab295c24cbc199c7f2aa15
ToppCell	(7)_Epithelial-H_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	GTPBP4 ANXA8L1 DDR1 LAMC2 ANXA8 FAM83B MUC4	5.75e-05	184	236	7	1f76b37c265b519171b767a52d48f31f0cdc4a3c
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC13D SEMA3B UTRN DDR1 LAMC2 CELSR1 CDH1	5.75e-05	184	236	7	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 CFAP65 DNAAF3 DYNC2I1 DNAH1 CFAP74 HDC	5.75e-05	184	236	7	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 CFAP65 DNAAF3 DYNC2I1 DNAH1 CFAP74 HDC	5.75e-05	184	236	7	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 CFAP65 DNAAF3 DYNC2I1 DNAH1 CFAP74 HDC	5.75e-05	184	236	7	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|tumor_Lung / Location, Cell class and cell subclass	ANXA8L1 BDKRB1 SH3GL3 ANXA8 LOX BRINP2 TNXB	5.75e-05	184	236	7	b0a251030d127858e68cf164be158f209a4d720f
ToppCell	CV-Healthy-7\|Healthy / Virus stimulation, Condition and Cluster	RAB19 ZBED4 GLS DOCK9 TEP1 AP4E1 IGHMBP2	5.95e-05	185	236	7	1979d189c204f4c2893e3170a514ee7d5523406c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GDAP1L1 PTPRD GOLIM4 NPHS1 FRY SAMD11 LOX	6.15e-05	186	236	7	1094c7140131454b2583200e1c01e81ccab3db23
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC13D SEMA3B UTRN DDR1 LAMC2 CELSR1 CDH1	6.15e-05	186	236	7	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	UNC13D SEMA3B DDR1 LAMC2 ANXA8 BRINP2 CDH1	6.36e-05	187	236	7	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RYR3 PTPRD GOLIM4 NPHS1 FRY SAMD11 LOX	6.36e-05	187	236	7	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CDK14 PTPRD GAREM1 TRIM2 CELSR1 FUT9 MUC4	6.36e-05	187	236	7	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	COVID-19_Mild-Neu_4\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	TBC1D9B CENPB LFNG CCNA2 MASTL TMPO APPL1	6.36e-05	187	236	7	714851e757c71c559ee6413a3f61d6c117c79ad2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13D GLS SEMA3B SH3GL3 LAMC2 CELSR1 CDH1	6.58e-05	188	236	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BRINP3 RYR3 TRANK1 DMD KIF26B LAMC2 SAMD11	6.80e-05	189	236	7	da9ecc0d7b81c1901f30f97bb44112dc85444a66
Drug	Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SETD1A ZZEF1 CXCR4 AP5Z1 COL6A1 TRIM2 TTC28 RASGRF1 CELSR3 SND1 GPR68 IGHMBP2 FUT9 IKBKB	1.94e-08	200	232	14	7007_UP
Drug	Caffeic acid [3331-39-5]; Down 200; 22.2uM; PC3; HT_HG-U133A	KIF1A IKZF1 BRINP1 RYK GFOD2 CXCR4 NFKBIB HELZ CELSR3 CA5B CDH1	4.96e-06	193	232	11	6753_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A	SETD1A TMC7 CDK14 AP5Z1 NFKBIB COL6A1 TRIM2 DOCK9 TEP1 GTF3C2 LOX	6.33e-06	198	232	11	2057_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A	SETD1A CENPB CDK14 PCNX2 PIK3C2B PIK3R1 AP5Z1 NFKBIB NUP160 CEP97 TNK2	6.33e-06	198	232	11	2348_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A	PEX6 BCL2L1 CUL7 CDK14 TULP3 TRANK1 SYNE1 CHST8 RPAP1 STX11 NCKAP1L	6.64e-06	199	232	11	2449_DN
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A	TBC1D9B KIF1A BCL2L1 TULP3 AP5Z1 CHST12 CEP97 SEC14L1 CHST8 RPAP1 IGHMBP2	6.64e-06	199	232	11	1703_DN
Drug	mangiferin	SREBF1 TLR7 BCL2L1 CXCR4 NFKBIB NQO1 CSF3 IKBKB CDH1	1.66e-05	143	232	9	ctd:C013592
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	CDK14 BDKRB1 CXCR4 NFKBIB TRIM2 RASGRF1 FRY LOX ELK3 CA5B	2.22e-05	186	232	10	5597_UP
Drug	Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	SETD1A BDKRB1 CXCR4 CAMSAP1 UTRN TRIM2 LAMC2 ZFPL1 CA5B GPR176	2.79e-05	191	232	10	6498_UP
Drug	Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	BRINP3 RSAD1 FYCO1 KRCC1 FBXO9 PIK3R1 CDC16 GOLIM4 PPFIA3 MUTYH	2.92e-05	192	232	10	4801_DN
Drug	Omeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A	SETD1A IKZF1 RYK TRANK1 PTPRN2 GLS UTRN PIGO TEP1 NCKAP1L	3.19e-05	194	232	10	2467_DN
Drug	2-propylpentanoic acid; Up 200; 2000uM; MCF7; HG-U133A	TULP3 CHST12 CAMSAP1 COL6A1 TRIM2 SH3GL3 LAMC2 IGHMBP2 TNK2 ELK3	3.19e-05	194	232	10	346_UP
Drug	Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A	ADAM11 CUL7 TRANK1 GLS CAMSAP1 CEP97 DNAJC4 TRIM2 SYNE1 IGHMBP2	3.19e-05	194	232	10	5701_UP
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	EPPK1 MAN2C1 CDK14 DMXL1 FBXO9 CXCR4 PIK3R1 TTC28 ZFPL1 MORC3	3.33e-05	195	232	10	2104_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A	TOR4A ANKRD27 FBXO9 ZBED4 TTC28 PPFIA3 TNK2 KDM2A IKBKB CDH1	3.48e-05	196	232	10	2119_DN
Drug	Cortisone [53-06-5]; Up 200; 11uM; MCF7; HT_HG-U133A	TMC7 ADAM11 CXCR4 CAMSAP1 PIGO CCDC93 TTC28 SND1 IKBKB GPR176	3.64e-05	197	232	10	7458_UP
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A	BRINP1 NYNRIN AP5Z1 FBXO41 CCDC93 RPGRIP1 DNAJC4 LAMC2 ZFPL1 CA5B	3.64e-05	197	232	10	5495_UP
Drug	Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A	SH3BP1 TRANK1 AP5Z1 GLS NFKBIB FBXO41 COL6A1 FRY TNK2 CDH11	3.64e-05	197	232	10	3514_UP
Drug	Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A	IKZF1 ZZEF1 NYNRIN GLS FBXO41 UTRN COL6A1 PLXNC1 GPR68 IGHMBP2	3.64e-05	197	232	10	6514_UP
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; HL60; HT_HG-U133A	TULP3 FBXO41 NUP160 PIGO CCDC93 SYNE1 ANKRD26 PLXNC1 GPR68 KDM2A	3.64e-05	197	232	10	2569_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	TOR4A GFOD2 GLS NFKBIB GAREM1 SEC14L1 DOCK9 CYFIP2 CELSR2 GTF3C2	3.64e-05	197	232	10	3005_DN
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	IKZF1 CUL7 GLS CAMSAP1 TTC28 SH3GL3 ANKRD26 AP4E1 ZBTB44 IGHMBP2	3.64e-05	197	232	10	5274_DN
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; HL60; HT_HG-U133A	GTPBP4 BCL2L1 PTPRN2 GFOD2 NFKBIB NUP160 CCDC93 SEC14L1 CELSR3 KDM2A	3.64e-05	197	232	10	2484_DN
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; HL60; HT_HG-U133A	KIF1A BRINP1 BCL2L1 RYK GLS FBXO41 CAMSAP1 SEC14L1 RPAP1 CDH1	3.64e-05	197	232	10	2357_UP
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A	SREBF1 IKZF1 TRANK1 NFKBIB SYNE1 DOCK9 SND1 PLXNC1 LOX TNK2	3.79e-05	198	232	10	6681_DN
Drug	estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A	AHI1 TMC7 PEX6 FBXO9 GFOD2 SEMA3B APBB1 PPFIA3 AP4E1 SND1	3.79e-05	198	232	10	1208_UP
Drug	Butacaine [149-16-6]; Down 200; 13uM; PC3; HT_HG-U133A	TBC1D9B SOCS6 PCNX2 CXCR4 NYNRIN NFKBIB NUP160 COL6A1 ANKRD26 CHST8	3.96e-05	199	232	10	5748_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A	GTPBP4 ZZEF1 GLS NFKBIB SEMA3B PGBD5 COL6A1 PPFIA3 ZFPL1 GPR176	3.96e-05	199	232	10	6228_UP
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A	BRINP1 ZZEF1 ZBED4 AP5Z1 GLS NFKBIB FBXO41 TRIM2 TTC28 ZBTB44	3.96e-05	199	232	10	4725_DN
Drug	Se-methylselenocysteine	PIK3C2B PIK3R1 NQO1 COL6A1 SEMA4B CCNA2	6.78e-05	68	232	6	CID000114835
Drug	Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; MCF7; HT_HG-U133A	BRINP3 RSAD1 KRCC1 FBXO9 PIK3R1 CDC16 TRIM2 CCNA2 APPL1	8.81e-05	177	232	9	5026_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; PC3; HT_HG-U133A	AHI1 GFPT1 UTRN GAREM1 COL6A1 TRIM2 ZFPL1 CHST8 CA5B	8.81e-05	177	232	9	1822_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	EPPK1 SREBF1 CXCR4 GLS NUP160 SH3GL3 LAMC2 CYFIP2 CA5B	1.00e-04	180	232	9	5950_UP
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	RSAD1 KRCC1 FBXO9 PIK3R1 CDC16 GOLIM4 TRIM2 DYNC2I1 MUTYH	1.09e-04	182	232	9	6087_DN
Drug	BMS-488043	ITIH4 CXCR4 TNXB	1.19e-04	10	232	3	CID000507806
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	SREBF1 KRCC1 PIK3R1 GLS PIGO CCDC93 SEC14L1 ANKRD26 IGHMBP2	1.29e-04	186	232	9	1177_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A	AHI1 CENPB KRCC1 DMXL1 PCNX2 UTRN TRIM2 ANKRD26 WRAP53	1.57e-04	191	232	9	4289_DN
Drug	NSC 663284	NQO1 RASGRF1 CCNA2	1.62e-04	11	232	3	CID000379077
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A	AHI1 CXCR4 PIK3R1 COL6A1 TRIM2 SH3GL3 LOX CA5B CDH1	1.63e-04	192	232	9	1209_UP
Drug	Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A	KIF1A BCL2L1 ZZEF1 CXCR4 PIK3R1 NFKBIB COL6A1 CA5B CDH1	1.70e-04	193	232	9	6749_DN
Drug	Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A	BRINP1 BCL2L1 GAREM1 RPGRIP1 COL6A1 KIF26B CHST8 CELSR2 IGHMBP2	1.70e-04	193	232	9	3086_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	GTPBP4 EPPK1 SOCS6 FBXO9 PIK3R1 GLS PIGO PGBD5 AP4E1	1.70e-04	193	232	9	3258_DN
Drug	Fluorometholone [426-13-1]; Up 200; 10.6uM; HL60; HT_HG-U133A	BCL2L1 SH3TC1 SEC14L1 TRIM2 SYNM LFNG ELK3 STX11 MUC4	1.70e-04	193	232	9	2509_UP
Drug	Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; HL60; HT_HG-U133A	CDK14 RYK UTRN NUP160 FRY GTF3C2 TMPO KDM2A IKBKB	1.70e-04	193	232	9	2166_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	CUL7 ANKRD27 ZBED4 XPO6 SEMA3B TRIM2 DOCK9 ANKRD26 IKBKB	1.77e-04	194	232	9	1670_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CDK14 TRANK1 CAMSAP1 COL6A1 PPFIA3 ZFPL1 SND1 PLXNC1 LOX	1.77e-04	194	232	9	4961_UP
Drug	PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A	TOR4A PCNX2 SH3TC1 PTPRN2 COL6A1 TEP1 SND1 PLXNC1 BRINP2	1.77e-04	194	232	9	5923_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; PC3; HT_HG-U133A	KIF1A PEX6 CXCR4 APBB1 TEP1 CELSR3 IGHMBP2 IKBKB MUC4	1.77e-04	194	232	9	4660_UP
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	IMPG1 BRINP1 TRANK1 NFKBIB CAMSAP1 LAMC2 PPFIA3 TEP1 FURIN	1.77e-04	194	232	9	4951_UP
Drug	CP-645525-01 [287190-82-3]; Up 200; 10uM; PC3; HT_HG-U133A	TMC7 BCL2L1 NFKBIB SEMA3B CAMSAP1 GAREM1 COL6A1 CA5B GPR176	1.77e-04	194	232	9	7527_UP
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	SETD1A SOCS6 CUL7 BDKRB1 SH3TC1 COL6A1 LAMC2 APOB ZFPL1	1.77e-04	194	232	9	4642_UP
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	TMC7 CXCR4 GLS SEMA3B GOLIM4 TRIM2 ANKRD26 RPAP1 CELSR2	1.83e-04	195	232	9	1660_UP
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A	KIF1A ZBED4 CXCR4 GOLIM4 UTRN SEC14L1 ZFPL1 PLXNC1 TMPO	1.83e-04	195	232	9	4508_DN
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	TBC1D9B AHI1 SREBF1 CAMSAP1 NUP160 PPFIA3 WRAP53 RPAP1 KDM2A	1.83e-04	195	232	9	1207_DN
Drug	Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; HL60; HT_HG-U133A	CENPB BRINP1 ZZEF1 ADAMTS20 PIGO TRIM2 RBP3 PLXNC1 CDH11	1.83e-04	195	232	9	2736_UP
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	SOCS6 PCNX2 SH3TC1 NFKBIB SEMA3B CELSR3 PLXNC1 LOX ELK3	1.83e-04	195	232	9	6670_DN
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	BCL2L1 CUL7 AP5Z1 NFKBIB NUP160 PIGO ZFPL1 RPAP1 GTF3C2	1.83e-04	195	232	9	4360_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	KIF1A GLS NFKBIB SEMA3B CEP97 CCDC93 GAREM1 PPFIA3 ZFPL1	1.83e-04	195	232	9	6795_DN
Drug	Lutein	IFT172 BCL2L1 KIF9 NQO1 ALS2	1.85e-04	52	232	5	ctd:D014975
Drug	(+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A	MAN2C1 BCL2L1 CUL7 ZBED4 GLS SEC14L1 ANKRD26 TEP1 AP4E1	1.91e-04	196	232	9	6798_DN
Drug	Roxarsone [121-19-7]; Up 200; 15.2uM; HL60; HT_HG-U133A	GTPBP4 KIF1A PEX6 NFKBIB CAMSAP1 LAMC2 ZFPL1 CHST8 HYAL2	1.91e-04	196	232	9	2950_UP
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A	SETD1A TMC7 TRANK1 FBXO9 NFKBIB TTC28 CHST8 IGHMBP2 TNK2	1.91e-04	196	232	9	1495_UP
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	BRINP1 ZZEF1 AP5Z1 NFKBIB COL6A1 TRIM2 TTC28 ZBTB44 RPAP1	1.91e-04	196	232	9	4718_DN
Drug	Rolitetracycline [751-97-3]; Up 200; 7.6uM; HL60; HT_HG-U133A	SH3BP1 PTPRN2 NQO1 CAMSAP1 PIGO PGBD5 LFNG CHST8 AP4E1	1.91e-04	196	232	9	3031_UP
Drug	Ronidazole [7681-76-7]; Up 200; 20uM; PC3; HT_HG-U133A	TMC7 PEX6 AP5Z1 CCDC93 RPAP1 TNK2 CA5B CDH1 MUC4	1.91e-04	196	232	9	7131_UP
Drug	Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; HL60; HT_HG-U133A	IKZF1 TULP3 TRANK1 GFOD2 NFKBIB FBXO41 COL6A1 CYFIP2 KDM2A	1.91e-04	196	232	9	2576_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; HL60; HT_HG-U133A	CENPB CUL7 GLS CEP97 CHST8 CELSR3 FURIN STX11 NCKAP1L	1.91e-04	196	232	9	2431_DN
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A	AHI1 TOR4A RYK GLS HELZ UTRN TMPO TNK2 CA5B	1.98e-04	197	232	9	4556_DN
Drug	Altretamine [654-05-6]; Up 200; 19uM; PC3; HT_HG-U133A	SETD1A IKZF1 ADAM11 SOCS6 PIK3R1 PIGO DNAJC4 APBB1 CA5B	1.98e-04	197	232	9	4627_UP
Drug	Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A	CUL7 NFKBIB SEMA3B COL6A1 LAMC2 ZFPL1 PLXNC1 TMPO CDH1	1.98e-04	197	232	9	4233_DN
Drug	Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	AHI1 PEX6 IKZF1 CXCR4 NFKBIB PPFIA3 TEP1 FURIN TNK2	1.98e-04	197	232	9	4959_UP
Drug	Sulmazole [73384-60-8]; Down 200; 14uM; MCF7; HT_HG-U133A	SETD1A CXCR4 NYNRIN FBXO41 UTRN SH3GL3 ZBTB44 IGHMBP2 IKBKB	1.98e-04	197	232	9	4127_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	FBXO9 GLS NFKBIB SEMA3B UTRN TRIM2 PPFIA3 ZFPL1 AP4E1	1.98e-04	197	232	9	6787_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A	TOR4A CEP97 ANKRD26 WRAP53 CHST8 CELSR3 RPAP1 FURIN NCKAP1L	1.98e-04	197	232	9	2554_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	GTPBP4 AHI1 FBXO9 HELZ PIGO ZFPL1 AP4E1 ZBTB44 BRINP2	1.98e-04	197	232	9	5201_DN
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A	ZZEF1 TRANK1 CXCR4 FBXO41 ADAMTS20 CAMSAP1 COL6A1 SH3GL3 IGHMBP2	1.98e-04	197	232	9	4992_UP
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	AHI1 BCL2L1 PCNX2 NFKBIB COL6A1 SYNE1 CHST8 CELSR1 DIP2C	1.98e-04	197	232	9	6180_UP
Drug	Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; PC3; HT_HG-U133A	GTPBP4 EPPK1 TULP3 PIK3R1 UTRN TMPO ELK3 CDH1 GPR176	1.98e-04	197	232	9	5106_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ZZEF1 PCNX2 GFOD2 UTRN ABCG5 DOCK9 SH3GL3 ZFPL1 AP4E1	2.06e-04	198	232	9	6001_UP
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A	SH3BP1 SREBF1 F12 PTPRN2 GFOD2 NQO1 CAMSAP1 NPHS1 SYNM	2.06e-04	198	232	9	2155_UP
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; HL60; HT_HG-U133A	PLPPR3 F12 TULP3 PIK3R1 ANKRD26 LAMC2 RPAP1 GTF3C2 PLXNC1	2.06e-04	198	232	9	1838_UP
Drug	Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A	KIF1A CUL7 GLS NFKBIB PGBD5 DNAJC4 ANKRD26 PPFIA3 CELSR2	2.06e-04	198	232	9	3406_UP
Drug	Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	SETD1A SOCS6 TULP3 PCNX2 CAMSAP1 GAREM1 TEP1 ZFPL1 STX11	2.06e-04	198	232	9	2372_UP
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A	GTPBP4 SETD1A KIF1A TULP3 NFKBIB CCDC93 CYFIP2 AP4E1 ZBTB44	2.06e-04	198	232	9	3259_DN
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; HL60; HT_HG-U133A	GTPBP4 TULP3 PTPRN2 AP5Z1 SYNE1 ANKRD26 ZFPL1 AP4E1 MUTYH	2.06e-04	198	232	9	2910_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A	TMC7 PCNX2 ZBED4 PTPRN2 UTRN CCDC93 ANKRD26 TEP1 IKBKB	2.06e-04	198	232	9	5799_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; HL60; HT_HG-U133A	PEX6 SOCS6 CUL7 NKRF SH3TC1 NQO1 PIGO CCDC93 RPAP1	2.06e-04	198	232	9	1853_DN
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	GTPBP4 RYK PCNX2 NUP160 PIGO ANKRD26 LOX TMPO IKBKB	2.06e-04	198	232	9	1145_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A	IKZF1 SH3TC1 NYNRIN CAMSAP1 UTRN TEP1 PLXNC1 LOX GPR176	2.06e-04	198	232	9	4830_UP
Drug	Cholecalciferol [67-97-0]; Up 200; 10.4uM; HL60; HT_HG-U133A	KIF1A PCNX2 FBXO41 PPFIA3 CYFIP2 GPR68 LOX MUC4 CDH11	2.06e-04	198	232	9	2436_UP
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	AHI1 PEX6 BCL2L1 AP5Z1 NUP160 COL6A1 CYFIP2 GTF3C2 SND1	2.06e-04	198	232	9	5852_DN
Drug	Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A	IKZF1 SH3TC1 CXCR4 GLS RPGRIP1 ZFPL1 ZBTB44 GPR68 IKBKB	2.06e-04	198	232	9	2316_UP
Drug	Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; MCF7; HT_HG-U133A	AHI1 DMXL1 CXCR4 CAMSAP1 SEC14L1 DNAJC4 COL6A1 CELSR3 PLXNC1	2.06e-04	198	232	9	6042_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A	MAN2C1 CXCR4 NUP160 SEC14L1 DNAJC4 APOO PPFIA3 CELSR3 TNK2	2.06e-04	198	232	9	2767_DN
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; PC3; HT_HG-U133A	PTPRN2 CXCR4 PIK3R1 SEMA3B CAMSAP1 APBB1 CELSR3 BRINP2 MUC4	2.06e-04	198	232	9	5763_UP
Drug	Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; PC3; HT_HG-U133A	TBC1D9B AHI1 PEX6 TOR4A BCL2L1 NUP160 COL6A1 RPAP1 IKBKB	2.06e-04	198	232	9	5880_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A	SREBF1 IKZF1 CDK14 AP5Z1 NFKBIB COL6A1 DOCK9 PPFIA3 GPR176	2.06e-04	198	232	9	3258_UP
Drug	Gliquidone [33342-05-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	IKZF1 CUL7 GLS UTRN COL6A1 RASGRF1 LAMC2 AP4E1 IKBKB	2.13e-04	199	232	9	6505_UP
Drug	Felbinac [5728-52-9]; Up 200; 18.8uM; HL60; HT_HG-U133A	DLGAP1 TMC7 IMPG1 BRINP1 ADAM11 RASGRF1 KIF26B RBP3 AP4E1	2.13e-04	199	232	9	3061_UP
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A	TMC7 ZBED4 AP5Z1 UTRN COL6A1 ANKRD26 ZFPL1 CHST8 SND1	2.13e-04	199	232	9	5788_DN
Disease	Colorectal Carcinoma	BRINP1 GDAP1L1 PTPRD SH3TC1 PTPRN2 NQO1 DMD DNAH8 PIGO CCDC93 RELCH SYNE1 RBP3 TSPEAR APOB CHST8 RPAP1 DIP2C KDM2A EIF3H CDH1 MUTYH HDC	8.88e-09	702	231	23	C0009402
Disease	creatinine measurement	RAB19 GTPBP4 RASL12 F12 PIK3R1 ABCG5 NPHS1 TPCN2 KIF26B FBXL17 LFNG CCNA2 FAM83B AP4E1 FRY CELSR3 CELSR2 SND1 PLXNC1 DIP2C KIAA1755 TNK2 MBD5	4.02e-06	995	231	23	EFO_0004518
Disease	Liver Cirrhosis, Experimental	SREBF1 TOR4A FBXO9 PTPRD AFP GLS ABCG5 COL6A1 CCNA2 FRY CSF3 SAMD11 GPR68 LOX APPL1 PLIN3 NCKAP1L	1.40e-04	774	231	17	C0023893
Disease	Liver diseases	BCL2L1 AFP NQO1 ASAH2 CSF3	2.57e-04	72	231	5	C0023895
Disease	Liver Dysfunction	BCL2L1 AFP NQO1 ASAH2 CSF3	2.57e-04	72	231	5	C0086565
Disease	retinitis pigmentosa (is_implicated_in)	IMPG1 FSCN2 RPGRIP1 RAX2	2.95e-04	41	231	4	DOID:10584 (is_implicated_in)
Disease	androstenedione measurement, estrone measurement	CDK14 PTPRD PGBD5	3.54e-04	18	231	3	EFO_0007970, EFO_0007972
Disease	Familial hemophagocytic lymphohistiocytosis	UNC13D STX11	3.62e-04	4	231	2	cv:C0272199
Disease	lung adenocarcinoma (is_marker_for)	IKZF1 CXCR4 PIK3R1 WRAP53 MUC4	5.55e-04	85	231	5	DOID:3910 (is_marker_for)
Disease	muscular dystrophy (implicated_via_orthology)	DMD UTRN TRIM2	5.68e-04	21	231	3	DOID:9884 (implicated_via_orthology)
Disease	cytotoxicity measurement, response to metformin	KIF1A SH3TC1 GOLIM4	5.68e-04	21	231	3	EFO_0006952, GO_1901558
Disease	Familial Hemophagocytic Lymphocytosis	UNC13D STX11	6.01e-04	5	231	2	C0272199
Disease	Leiomyosarcoma, Epithelioid	DMD CSF3	6.01e-04	5	231	2	C0205815
Disease	Leiomyosarcoma, Myxoid	DMD CSF3	6.01e-04	5	231	2	C0205816
Disease	leiomyosarcoma	DMD CSF3	6.01e-04	5	231	2	C0023269
Disease	Malignant neoplasm of breast	TBC1D9B MAN2C1 GIMAP1 PTPRD CXCR4 AFP NQO1 GOLIM4 DMD SYNE1 MAMDC4 NLRP9 CSF3 DIP2C APPL1 ELK3 HADHB IKBKB CDH1	8.52e-04	1074	231	19	C0006142
Disease	acute lymphoblastic leukemia (is_implicated_in)	IKZF1 BCL2L1 NQO1 CSF3	9.13e-04	55	231	4	DOID:9952 (is_implicated_in)
Disease	embryonal carcinoma (is_marker_for)	AFP CCNA2	1.25e-03	7	231	2	DOID:3308 (is_marker_for)
Disease	cadherin-15 measurement	F12 ITIH4	1.25e-03	7	231	2	EFO_0020211
Disease	LDL cholesterol change measurement	APOB CELSR2	1.25e-03	7	231	2	EFO_0007804
Disease	hereditary spastic paraplegia (is_implicated_in)	KIF1A AP5Z1	1.25e-03	7	231	2	DOID:2476 (is_implicated_in)
Disease	Retinitis Pigmentosa	AHI1 IFT172 FSCN2 RPGRIP1 RBP3	1.38e-03	104	231	5	C0035334
Disease	Muscular Dystrophy	DMD COL6A1	1.66e-03	8	231	2	C0026850
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	APOB CELSR2	1.66e-03	8	231	2	EFO_0008589, EFO_0008595
Disease	response to darapladib, cardiovascular event measurement	ACOT6 ANO3	1.66e-03	8	231	2	EFO_0006919, EFO_0008395
Disease	common bile duct neoplasm (is_marker_for)	APOB MUC4	1.66e-03	8	231	2	DOID:4608 (is_marker_for)
Disease	corneal topography	PKD1L1 ADAMTS20 COL6A1 RBP3 EIF3H	1.70e-03	109	231	5	EFO_0004345
Disease	low density lipoprotein cholesterol measurement, physical activity	CXCR4 NYNRIN APOB CELSR2	1.80e-03	66	231	4	EFO_0003940, EFO_0004611
Disease	Ovarian Mucinous Adenocarcinoma	CDK14 RYK TNK2	1.81e-03	31	231	3	C1335167
Disease	vital capacity	AHI1 KIF1A UNC13D BCL2L1 ZZEF1 GFPT1 PTPRD PIK3C2B CXCR4 PIK3R1 UTRN PPP1R21 SYNE1 PCDHAC1 APOB ATE1 LOX KDM2A EIF3H TNXB	1.82e-03	1236	231	20	EFO_0004312
Disease	Ehlers-Danlos syndrome (is_implicated_in)	LOX TNXB	2.12e-03	9	231	2	DOID:13359 (is_implicated_in)
Disease	cognitive disorder (is_implicated_in)	DMD CSF3	2.12e-03	9	231	2	DOID:1561 (is_implicated_in)
Disease	biological sex	BRINP3 ADAM11 DNAAF3 NUP160 TTC28 FBXL17 FUT9	2.33e-03	230	231	7	PATO_0000047
Disease	nephrotic syndrome	AHI1 PTPRD NPHS1 TNXB	2.36e-03	71	231	4	EFO_0004255
Disease	omega-3 polyunsaturated fatty acid measurement	AHI1 CXCR4 APOB CELSR2 IGHMBP2	2.41e-03	118	231	5	EFO_0010119
Disease	Muscle Weakness	DMD CSF3	2.63e-03	10	231	2	C0151786
Disease	dipeptidase 2 measurement	F12 ITIH4	2.63e-03	10	231	2	EFO_0801528
Disease	hepatocellular carcinoma (is_marker_for)	IKZF1 ITIH4 CXCR4 AFP DDR1 WRAP53 CDH1 KDM1A	2.69e-03	301	231	8	DOID:684 (is_marker_for)
Disease	electroencephalogram measurement	SGSM1 PCNX2 PTPRD DMD	2.74e-03	74	231	4	EFO_0004357
Disease	coronary artery disease	KIF1A SREBF1 UNC13D ITIH4 DMXL1 DNAAF3 GLS CHST12 NUP160 DOCK9 FBXL17 RNF213 APOB FAM83B AP4E1 CELSR2 LOX FURIN TNXB	2.83e-03	1194	231	19	EFO_0001645
Disease	Intellectual Disability	SETD1A ZNF142 AHI1 PEX6 PITRM1 SYNE1 RTTN CCNA2 AP4E1 FRY	2.91e-03	447	231	10	C3714756
Disease	angina pectoris	BRINP1 RNF213 APOB CELSR2 FURIN	3.09e-03	125	231	5	EFO_0003913
Disease	Jeune thoracic dystrophy	IFT172 DYNC2I1	3.20e-03	11	231	2	C0265275
Disease	transient cerebral ischemia (is_implicated_in)	F12 CSF3	3.20e-03	11	231	2	DOID:224 (is_implicated_in)
Disease	pulse pressure measurement	UNC13D CDK14 RYK TRANK1 PTPRD CDC16 NUP160 CEP97 PTCD3 COL6A1 TTC28 FBXL17 PCDHAC1 RNF213 CCNA2 SND1 PLXNC1 FURIN KIAA1755 MBD5 KDM1A	3.23e-03	1392	231	21	EFO_0005763
Disease	hepatocyte growth factor-like protein measurement	NICN1 DNAH1 CELSR3	3.26e-03	38	231	3	EFO_0008154
Disease	thioredoxin domain-containing protein 12 measurement	FYCO1 NICN1 CELSR3	3.52e-03	39	231	3	EFO_0008298
Disease	serum alanine aminotransferase measurement	DLGAP1 PKD1L1 PEX6 TRANK1 PIK3R1 NYNRIN KLHL8 NUP160 ABCG5 PPP1R21 TPCN2 FBXL17 APOB CYFIP2 CELSR2	3.71e-03	869	231	15	EFO_0004735
Disease	lipoprotein-associated phospholipase A(2) measurement	RNF213 APOB CELSR2	3.78e-03	40	231	3	EFO_0004746
Disease	middle cerebral artery infarction (is_implicated_in)	F12 CSF3	3.82e-03	12	231	2	DOID:3525 (is_implicated_in)
Disease	persulfide dioxygenase ETHE1, mitochondrial measurement	F12 ITIH4	3.82e-03	12	231	2	EFO_0008258
Disease	acute myeloid leukemia (is_implicated_in)	CXCR4 NQO1 CSF3 CDH1	4.33e-03	84	231	4	DOID:9119 (is_implicated_in)
Disease	Multiple Myeloma	BCL2L1 NQO1 CSF3	4.34e-03	42	231	3	C0026764
Disease	Short Rib-Polydactyly Syndrome	IFT172 DYNC2I1	4.50e-03	13	231	2	C0036996
Disease	breast cancer (biomarker_via_orthology)	NQO1 KDM1A	4.50e-03	13	231	2	DOID:1612 (biomarker_via_orthology)
Disease	prostate carcinoma (is_implicated_in)	BCL2L1 EIF3H	4.50e-03	13	231	2	DOID:10286 (is_implicated_in)
Disease	Profound Mental Retardation	AHI1 PEX6 CCNA2 AP4E1 FRY	4.85e-03	139	231	5	C0020796
Disease	Mental deficiency	AHI1 PEX6 CCNA2 AP4E1 FRY	4.85e-03	139	231	5	C0917816
Disease	Mental Retardation, Psychosocial	AHI1 PEX6 CCNA2 AP4E1 FRY	4.85e-03	139	231	5	C0025363
Disease	unipolar depression, anxiety	BRINP1 PTPRD	5.22e-03	14	231	2	EFO_0003761, EFO_0005230
Disease	Majewski Syndrome	IFT172 DYNC2I1	5.22e-03	14	231	2	C0024507
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB CELSR2	5.22e-03	14	231	2	EFO_0004611, EFO_0008589
Disease	Saldino-Noonan Syndrome	IFT172 DYNC2I1	5.22e-03	14	231	2	C0036069
Disease	polycystic kidney disease (implicated_via_orthology)	IFT172 TULP3	5.22e-03	14	231	2	DOID:0080322 (implicated_via_orthology)
Disease	total lipids in very small VLDL measurement	ABCG5 APOB CELSR2	5.27e-03	45	231	3	EFO_0022156
Disease	interleukin 17 measurement	UTRN NUP160 EPHA8	5.27e-03	45	231	3	EFO_0008174
Disease	Gastric Adenocarcinoma	TNK2 BRSK1 EPHA8	5.27e-03	45	231	3	C0278701
Disease	total lipids in small LDL	NYNRIN APOB CELSR2	5.96e-03	47	231	3	EFO_0022168
Disease	Gastrointestinal Stromal Sarcoma	IFT172 TULP3 DMD	5.96e-03	47	231	3	C3179349
Disease	response to statin, LDL cholesterol change measurement	APOB CELSR2	5.99e-03	15	231	2	EFO_0007804, GO_0036273
Disease	Hypertriglyceridemia	APOB CELSR2	5.99e-03	15	231	2	C0020557
Disease	B-cell acute lymphoblastic leukemia	IKZF1 ELK3	5.99e-03	15	231	2	EFO_0000094
Disease	Cardiomyopathy, Dilated	DMD CSF3 TMPO	6.32e-03	48	231	3	C0007193
Disease	Colorectal Neoplasms	PTPRD SH3TC1 NQO1 SYNE1 KDM2A EIF3H CDH1	6.39e-03	277	231	7	C0009404
Disease	resting heart rate	EPPK1 SREBF1 GAREM1 FBXL17 KIAA1755	6.48e-03	149	231	5	EFO_0004351
Disease	phospholipids in medium LDL measurement	NYNRIN APOB CELSR2	6.69e-03	49	231	3	EFO_0022183
Disease	cholesterol in medium LDL measurement	NYNRIN APOB CELSR2	6.69e-03	49	231	3	EFO_0022224
Disease	breast carcinoma	SREBF1 KIF9 PTPRD PTPRN2 PIK3R1 DMD GAREM1 TPCN2 TTC28 ARHGEF5 ANKRD26 ATE1 FAM83B PLXNC1 BRSK1 LRRD1	6.76e-03	1019	231	16	EFO_0000305
Disease	autism spectrum disorder (is_implicated_in)	AHI1 MBD5	6.81e-03	16	231	2	DOID:0060041 (is_implicated_in)
Disease	Polyposis, Adenomatous Intestinal	ITIH4 MUTYH	6.81e-03	16	231	2	C2713442
Disease	Familial Intestinal Polyposis	ITIH4 MUTYH	6.81e-03	16	231	2	C2713443
Disease	osteosarcoma (is_implicated_in)	CXCR4 DDR1	6.81e-03	16	231	2	DOID:3347 (is_implicated_in)
Disease	response to acetylsalicylate	DNAAF3 KIF9	6.81e-03	16	231	2	GO_1903492
Disease	Cardiomyopathy, Familial Idiopathic	DMD CSF3 TMPO	7.08e-03	50	231	3	C1449563
Disease	Gastrointestinal Stromal Tumors	IFT172 TULP3 DMD	7.08e-03	50	231	3	C0238198
Disease	multiple sclerosis	SETD1A AHI1 EPPK1 IKZF1 BRINP1 CXCR4 CHST12 TRIM2 TTC28 RASGRF1 PLXNC1	7.48e-03	594	231	11	MONDO_0005301
Disease	phospholipids in very small VLDL measurement	ABCG5 APOB CELSR2	7.48e-03	51	231	3	EFO_0022300
Disease	free cholesterol to total lipids in small HDL percentage	ABCG5 APOB CELSR2	7.48e-03	51	231	3	EFO_0022285
Disease	Mammary Neoplasms, Experimental	AFP PIK3R1 DDR1 FURIN CDH1	7.62e-03	155	231	5	C0024668
Disease	Carcinoma in situ of stomach	CDH1 MUTYH	7.68e-03	17	231	2	C0154060
Disease	Benign neoplasm of stomach	CDH1 MUTYH	7.68e-03	17	231	2	C0153943
Disease	Herpes Zoster	TMC7 LRRC32	7.68e-03	17	231	2	EFO_0006510
Disease	Neoplasm of uncertain or unknown behavior of stomach	CDH1 MUTYH	7.68e-03	17	231	2	C0496905
Disease	Adenomatous Polyposis Coli	ITIH4 MUTYH	7.68e-03	17	231	2	C0032580
Disease	lateral occipital cortex volume measurement	BRINP1 UTRN	7.68e-03	17	231	2	EFO_0010311
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2	7.68e-03	17	231	2	EFO_0022232
Disease	banks of the superior temporal sulcus volume measurement	PGBD5 ATE1	7.68e-03	17	231	2	EFO_0010286
Disease	myocardial infarction (is_implicated_in)	BRINP3 F12 ITIH4 CSF3	7.72e-03	99	231	4	DOID:5844 (is_implicated_in)
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	NYNRIN TRIM2 APOB CELSR2	7.72e-03	99	231	4	EFO_0004611, EFO_0007878

Protein segments in the cluster

Peptide	Gene	Start	Entry
IQADYHRRSLSSLDT	BARGIN	241	Q6ZT62
YLEERGRHQVLSLSA	MAMDC4	906	Q6UXC1
TLHQLAASYFIDRDS	BRINP3	176	Q76B58
FNYHILASLRTREEV	BDKRB1	221	P46663
TVRSSFRHDYVLNVQ	CA5B	291	Q9Y2D0
HFTIRLTESASTYRD	CDY1	271	Q9Y6F8
RALLDSQFSYQHAIE	EIF3H	131	O15372
SLDRYLAIVHATNSQ	CXCR4	131	P61073
IHGNSSDRLSSIRVY	CCDC169	86	A6NNP5
VEALHQLASSYFVDR	BRINP1	161	O60477
DYTANRSDELTIHRG	AHI1	1061	Q8N157
YIASLHELATTERRF	ALS2	691	Q96Q42
SRAHLEKESIAQRSY	ALG5	196	Q9Y673
EASYLRSLNIAVDHF	ARHGEF5	1186	Q12774
ARDNTINLIHTFRDY	ARPC2	236	O15144
YLATLNFVHRDLATR	DDR1	756	Q08345
SYFEARNTAQHLTVS	MASTL	861	Q96GX5
DAHYAVQARRSRSIT	GTPBP4	536	Q9BZE4
LEIQADYHRRSLSSL	SH3BP1	231	Q9Y3L3
DYHRRSLSSLDTALA	SH3BP1	236	Q9Y3L3
HLLSSQYVERHFSRE	ADAM11	106	O75078
TSQRAFVALYVASHR	ANKRD60	216	Q9BZ19
YRRAFSDLTSQLHIT	BCL2L1	101	Q07817
SEFYAQIASERLQAH	ACOT6	331	Q3I5F7
QIRSHSYLRAVSEVS	DLGAP1	401	O14490
LYSELELSAHNAANR	APBB1	116	O00213
AAVDSEAVYQHLFTR	AP5Z1	381	O43299
NRLSAQAALSHEYFS	CDK14	406	O94921
ENARLHYRLVDTAST	CELSR1	596	Q9NYQ6
VAYQLATRLLAHEST	CELSR2	2076	Q9HCU4
SATQRLEHAFNIARY	DMD	191	P11532
RLEAEVESYHSRLAA	ANKRD26	1001	Q9UPS8
LSTFYLLDHNTRQAE	CBY3	101	A6NI87
HYQQRTLTFALRADD	DCPS	311	Q96C86
FDSYRLHDESNQRTL	CAMSAP1	1166	Q5T5Y3
NLSERRLFFTTASAH	DMXL1	1851	Q9Y485
LEFSRTVHADLSNYD	DCUN1D5	201	Q9BTE7
VSRLEQDEYALRSHS	HADHB	236	P55084
FHPRQEALVRTLTSY	ADAMTS20	26	P59510
LRDDLNVTRLSHFEY	TNK2	26	Q07912
SEHATYDRSRLINDF	ANO3	116	Q9BYT9
ESLRRAELNHNVTYA	AP4E1	301	Q9UPM8
YSLTVDSRVSSRFAH	ITIH4	36	Q14624
SYRHREVSFLALDEQ	NBPF4	286	Q96M43
AHAFLVVYSVDSRQS	RASL12	91	Q9NYN1
HAAIIAYDLTRRSTF	RAB19	91	A4D1S5
RTTFTTYQLHQLERA	RAX2	31	Q96IS3
RVYLRTSNLDNAFAH	RIC1	566	Q4ADV7
VYESRLLATARHELN	IRX4	51	P78413
YATAEIRRHLANATT	GDAP1L1	176	Q96MZ0
QRDYDSRTALHVAAA	GLS	581	O94925
DRLYQEVHRLSATLG	PTPRN2	386	Q92932
CTRSATHLLRVFEEY	ANXA8	206	P13928
AYHLSFERRQKSSEA	ANKRD27	616	Q96NW4
LDRETQSHYSFRITA	PCDH19	196	Q8TAB3
DDLSHRVLAYLNSRN	OTOA	66	Q7RTW8
TFLANHDDSRALYAI	POLDIP2	156	Q9Y2S7
RLDIATHLFEAYSAL	RELCH	1106	Q9P260
LNARLVAYASDQAHS	HDC	181	P19113
YDTLALRNASIGLHT	MUC4	4921	Q99102
HSAELRETVSSFYRL	NPHS1	626	O60500
RLHADVYTFNALIEA	PTCD3	286	Q96EY7
QESAARKALIASSYH	OGFOD2	76	Q6N063
TALLHLACTRSYADE	OR10AC1	186	Q8NH08
SVYLDETLASSRHGR	HYAL2	251	Q12891
RTAEYQALVNFLSHE	LRRD1	106	A4D1F6
ALVRDVHSLSEYFSL	LFNG	66	Q8NES3
VHSLSEYFSLLTRAR	LFNG	71	Q8NES3
RAYEAAASALQIATH	TMPO	571	P42166
TQTLRIADHSLYALE	NEUROG3	136	Q9Y4Z2
YASQREAELHATLLS	GPR176	256	Q14439
LSDIASALRYLHENR	IKBKB	126	O14920
ARSQLEESISQLRHY	APOO	56	Q9BUR5
RSAAAQQLHLEIDSY	IMPG1	661	Q17R60
RSHLAAATALYSLVD	KIAA1755	806	Q5JYT7
AFIRYSLVHQRLADT	FYCO1	106	Q9BQS8
RYLSAQREATSLHDA	PPFIA3	311	O75145
SLYRRDNVILSGTHT	ASAH2	181	Q9NR71
LRASVHASFYSADLV	CFAP65	1506	Q6ZU64
RATVSHYECLSLERA	KIF26B	1671	Q2KJY2
IHTEATDYRRQAASA	KIAA1109	3511	Q2LD37
RIYDAQNELSAATHL	APPL1	46	Q9UKG1
SGIEHLFNLTLTYRR	FUT9	146	Q9Y231
LREDSRLHYSVTLSD	DYNC2I1	726	Q8WVS4
ANALYTHSRLRSSLV	FAM83B	531	Q5T0W9
YDDIVVHSSRSQTRL	NFKBIB	326	Q15653
RDYILSSGQDHLLTA	IDO2	331	Q6ZQW0
YSVARSVLAAALLHA	PCNX2	1001	A6NKB5
SLEHSLSRLYRDQAG	PLXNC1	71	O60486
LDEARNYHLHLSSRA	KLHL8	286	Q9P2G9
RHLSEGTNSYATRLL	MORC3	511	Q14149
VVGDLYALLTHSSRA	PEX6	631	Q13608
FLHRLTSVSRDYAVV	CUL7	731	Q14999
LHNIIRSAFYQISDS	DNAH8	1666	Q96JB1
SLSYARDELTQSFHR	GAREM1	371	Q9H706
SRSLFDIYHLSREAE	KIR3DL3	246	Q8N743
VINSLAVYRHRETDF	NPIPB8	41	E9PQR5
SEYLSSHLEARLNRA	NCKAP1L	706	P55160
FAHILLRYTNVENTS	MICU3	391	Q86XE3
ITINAAHVEYSTAAR	TUFM	106	P49411
AIHDSLTNRTFVTYD	KIF9	371	Q9HAQ2
EHRAYDLLRAASENS	IKZF1	431	Q13422
LTFSSVVELINHYRN	PIK3R1	396	P27986
LVTALLNFHTYTEQR	PPP1R21	266	Q6ZMI0
HIRFISELARYSNSE	CYFIP2	356	Q96F07
NRIDYVSSAVRIDHA	GTPBP8	91	Q8N3Z3
EQYRTFATALDTTRH	HAUS8	231	Q9BT25
YSEFARERNLHVSLL	HELZ	831	P42694
TTYSRFQDLIRELSH	HELZ	1571	P42694
ALIVLAHSERTSFNY	NQO1	6	P15559
VALYATHLIREGSSA	IFT172	1446	Q9UG01
RQALSLLFDTYHNEV	PIK3C2B	501	O00750
YLVLLHSLDREASAS	DCHS2	2616	Q6V1P9
SLSAQLQVVYEHRSR	GOLIM4	56	O00461
LSYHISRASDSSLFR	PCDHAC1	596	Q9H158
FYTALRHLDLSTNEI	LRRC32	71	Q14392
LEAARARYESLHISD	PGBD5	16	Q8N414
LEHLSSLAREVSLDY	DNAH1	431	Q9P2D7
IYGNSRFTDLHSIIR	EFCAB5	781	A4FU69
LRASHTSLQARYNEA	CCDC93	336	Q567U6
QRSRATLYALSHAVN	APOB	436	P04114
NEHARRYLSKATTLE	CDC16	316	Q13042
RYLTSFPIDDRVQSH	CENPB	556	P07199
SLHDYVSNTENRALR	GIMAP1	161	Q8WWP7
NAEEFYSSLISEIHR	FASTKD5	446	Q7L8L6
FERIASEASRLAHYN	H2BU1	71	Q8N257
EFNRLLEATSYLSHQ	KDM1A	381	O60341
YNVISLEFSHTRLEN	KDM2A	141	Q9Y2K7
CTRSATHLLRVFEEY	ANXA8L1	206	Q5VT79
DRYASRSHQARIATL	DOCK9	1151	Q9BZ29
ELRDSSAYHVPNRTL	DNAAF3	241	Q8N9W5
TAFSSIAHITRDVNY	MT-CYB	61	P00156
SIIATDHTYRRNFTA	COL6A1	201	P12109
TDAILLGHYRLSQDT	FBXO9	331	Q9UK97
SVHTTRYSRNDLHLE	CEP97	371	Q8IW35
TRSTLLAARPHDYSA	FURIN	511	P09958
SSQHLARRYAALAAE	FBXL17	96	Q9UF56
YVHRDLAARNVLVDS	EPHA8	756	P29322
FERIASEASRLAHYN	H2BC13	71	Q99880
AFYTSRTDDILLHQD	GFOD2	51	Q3B7J2
DAANSPIRYSIDRHT	CDH11	411	P55287
LDHLHYTTEFTRNDL	C6orf50	6	Q9HD87
SLHSRFVELSEAYRV	DNAJC4	71	Q9NNZ3
RYRSDVHTEAVQAAL	DIP2C	86	Q9Y2E4
SLSHVADRLIGNYSL	ABCG5	176	Q9H222
SSYILLHSVNSFARR	ADGRF2	261	Q8IZF7
HSVLSQTSFRAEYKA	BRSK1	636	Q8TDC3
LAALRSTSRNEYIHS	ELK3	126	P41970
FTYLDTRTLLHAAEV	FBXO41	561	Q8TF61
YEDIRSHGNTLLSAA	MAN2C1	596	Q9NTJ4
FSHYDLLDANTQRRV	LOX	301	P28300
SSNELIHYRPRTFNV	MBD5	1371	Q9P267
VYSALREIAFTRQLH	ATE1	381	O95260
VASHLQSFLEVSYRV	CSF3	186	P09919
QSFLEVSYRVLRHLA	CSF3	191	P09919
ADRSYQHSLRLLDSV	LAMC2	841	Q13753
AHDSRLRLDSLSYCQ	KRCC1	91	Q9NPI7
IRAHTRLESRYSNSS	FRY	1566	Q5TBA9
TLHLAVNYIDRFLSS	CCNA2	231	P20248
HYFSQDVRVTARLLA	CELSR3	2221	Q9NYQ7
RTLHIEAYNETFSNR	SEC14L1	91	Q92503
VRNDLISHYALSFSL	RYK	86	P34925
VINSLAVYRHRETDF	NPIPB6	41	E9PJ23
DRSTRAVSVHFTLYN	PKD1L1	2466	Q8TDX9
YDRLYQDSVLVHTRS	CFAP74	816	Q9C0B2
DRERIATYTLFSHAV	CDH1	221	P12830
TESRTLHRNEYGIAS	AFP	16	P02771
LRLLTHTFNREYTHS	KIF1A	1456	Q12756
ANSTVTSFQRYHEAL	NYNRIN	761	Q9P2P1
FLSHLAVVDIAYTRN	OR2A1;	61	Q8NGT9
YANVIAYDHSRVLLS	PTPRD	1386	P23468
YCFVSETTHRDLARL	GPR68	286	Q15743
RTALSNSPHSRYLAE	MUC3B	41	Q9H195
QLDTNRSVYDVFHLS	FSCN2	401	O14926
TLAVRSYRLHEAFSP	F12	441	P00748
LVELADQALRSFSYH	RTTN	571	Q86VV8
DHLSLYQLSLERGTA	RSAD1	221	Q9HA92
LEAFNSRYEDLSHLA	UTRN	1311	P46939
TDSLFLHYLQEASAR	RPGRIP1	686	Q96KN7
ASFRAYNHLDELTAA	WRAP53	266	Q9BUR4
AVFIEAALDYHRQST	SH3GL3	216	Q99963
RHRVSQLSSQYLALS	SYNE1	3251	Q8NF91
SYHYTDSLLQRENER	SYNM	341	O15061
YFASDASAVIEHTNR	GFPT1	276	Q06210
RNYARSESHTDLTFS	NKRF	611	O15226
SYRHREVSFLALDEQ	NBPF5P	286	Q86XG9
SYRHREVSFLALDEQ	NBPF6	286	Q5VWK0
SAHRAASLEAVSYAI	MOCS2	141	O96007
VQYSSSIHDREIRFN	MITD1	186	Q8WV92
SLSERLRQHAYEHSL	PLIN3	241	O60664
SYLSEARRDELLAQH	EPPK1	2666	P58107
SYLSEARRDELLAQH	EPPK1	3731	P58107
FSSYLSEAHRDELLA	EPPK1	4796	P58107
AFLSIRVRQYTSAHT	NICN1	56	Q9BSH3
YLHLAREDTNNLFSV	PITRM1	76	Q5JRX3
RFEAEHISNYTALLL	SEMA4B	61	Q9NPR2
HISNYTALLLSRDGR	SEMA4B	66	Q9NPR2
LTLYHRTSVTDFLRA	FTSJ3	246	Q8IY81
QRSSHYDELLAAEAR	SND1	471	Q7KZF4
YDSADLVAQLRAAHS	CCT2	456	P78371
TRLATIYHNFLLDRE	SH3TC1	1281	Q8TE82
HYRRLVSALSEASTF	SAMD11	191	Q96NU1
EVVLQASVSSYHLFR	MUTYH	71	Q9UIF7
ASVSSYHLFRDVAEV	MUTYH	76	Q9UIF7
FQLVSTESNRYSLDH	NUP160	371	Q12769
VAAIAHASYRTLATE	RASGRF1	121	Q13972
SSYLFRVDHDTIIDA	SETD1A	1621	O15047
HSFQSAYLIVDRDEA	SCRN1	151	Q12765
TAHNAIEKRYRSSIN	SREBF1	326	P36956
DSSARVAPYRILHQT	TBC1D9B	51	Q66K14
LETLHQLAASYFIDR	BRINP2	191	Q9C0B6
LSPRLDHTRAVNYFS	CLTC	1426	Q00610
ARTTARIAHQYFAQL	CHST8	381	Q9H2A9
RLYANHTSLPASARE	CHST12	276	Q9NRB3
NDAYTAAARRHTVVL	NLRP9	136	Q7RTR0
FREVAILYRSHNASL	RNF213	4376	Q63HN8
LFTTYDRRTNITQEH	RBP3	506	P10745
YAEVSNTFVRLADTH	POLR3C	141	Q9BUI4
LVSRLLEAHALYASS	TEP1	1576	Q99973
DALRALTQRGHDSVY	PLPPR3	301	Q6T4P5
DQELISLAKSRYSHR	RYR3	3386	Q15413
YVASRSAVAQIALHR	SEMA3B	501	Q13214
SHDFQLSLDRENSYR	IGHMBP2	121	P38935
HSAVARISRAQYNAL	STX11	121	O75558
LRIEERAFSYVLTHA	TOMT	76	Q8WZ04
RNDITLSGLESDHRY	TNXB	1931	P22105
LRSLNHEASELANYF	ZBTB44	506	Q8NCP5
RPSLSARDYVESLHQ	SGSM1	236	Q2NKQ1
ARDYVESLHQNSRAT	SGSM1	241	Q2NKQ1
ERAGYSLQELFHLTR	RPAP1	386	Q9BWH6
YLDFSNNRLDLLHST	TLR7	546	Q9NYK1
FRSVLEDSALVLQYH	TOR4A	211	Q9NXH8
AQHQLYRASALFETI	TTC28	1136	Q96AY4
YRASALFETIRHEAQ	TTC28	1141	Q96AY4
NEATAVLYARHVLAS	ZZEF1	2611	O43149
RFLHTYSAATQDLQA	PIGO	376	Q8TEQ8
LYRINRFSSITAHPE	GTF3C2	371	Q8WUA4
ERIFLAVANSHSYDV	TSPEAR	536	Q8WU66
DFSTTRRYRLEAHQS	ZNF142	1206	P52746
HASLISALSRDYRNL	XPO6	751	Q96QU8
RSRAESSHYFQSLEV	ZSWIM1	246	Q9BR11
FTLSLRLYDQHIRGS	TRIM2	401	Q9C040
DLRSLFHYASRNTID	TRANK1	1436	O15050
ATVASLLVFQYAARH	VSIG10L2	716	P0DP72
PRFSRHSTILDYINV	SIGLEC10	586	Q96LC7
TEASELLRYLQEAFH	UNC13D	76	Q70J99
AAHTRQELAAISYET	TULP3	296	O75386
SSDDRYLLSLSFRSH	SOCS6	411	O14544
ASRETTRLVCYDLFH	ZFPL1	61	O95159
AIQYRSINHRVDASS	TPCN2	56	Q8NHX9
YRHFTNTLILAVAAS	TMEM87A	401	Q8NBN3
IAENLSSHSLRNYAL	TMC7	81	Q7Z402
SRLSATLHDPRYVFA	ZBED4	991	O75132
STERSLRLQARYHDT	MYORG	251	Q6NSJ0